Based on the tumor-suppressor role of BCOR [9, 18], we investigated the impact of Bcor loss in the context of CLL evolution through the generation of an in vivo pre-clinical model. This evidence concerns the gene BCOR and B-cell chronic lymphocytic leukemia.